Clinical Trials in Portland

Showing 6321-6340 of 10,048 trials

Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients

NCT00686608

The purpose of this study is to identify how certain parts of the brain that control appetite respond to changes in dietary carbohydrate and fat.

Obesity

Oregon Health and Science University56 participantsStarted Oct 2006

Portland, Oregon, United States

COMPLETEDPhase 2< 1 mile

Radiation Therapy in Treating Young Patients With Gliomas

NCT00238264

RATIONALE: Specialized radiation therapy that delivers radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well radiation therapy works in treating young patients with gliomas.

Brain TumorCentral Nervous System Tumor

Children's Oncology Group92 participantsStarted Nov 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +142 more locations

Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients

Radiation Therapy in Treating Young Patients With Gliomas

Find Trials by Condition in Portland

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

Physical Activity and Obesity

Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Evaluation of the QuantiFERON-TB Test.

Pilot Trial of a Behavioral Treatment for Epilepsy

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

Study of MLN8237 in Combination With Irinotecan and Temozolomide

LOIS: Long-Term Follow-Up in INSITE/SIFI

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.